Research Article

Changes of Thymidine Kinase (TK) During Adjuvant and Palliative Chemotherapy

O. TOPOLCAN, L. HOLUBEC, J. FINEK, P. STIEBER, S. HOLDENRIEDER, R. LAMERZ, L. HOLUBEC SEN, S. SVOBODOVA, V. VISOKAI and L. LIPSKA
Anticancer Research May 2005, 25 (3A) 1831-1833;

Article Information

vol. 25 no. 3A 1831-1833
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received August 2, 2004
  • Accepted February 8, 2005
  • Published online May 1, 2005.
Copyright & Usage 
Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. O. TOPOLCAN1,
  2. L. HOLUBEC JR.1,
  3. J. FINEK1,
  4. P. STIEBER3,
  5. S. HOLDENRIEDER3,
  6. R. LAMERZ4,
  7. L. HOLUBEC SEN1,
  8. S. SVOBODOVA2,
  9. V. VISOKAI2 and
  10. L. LIPSKA2
  1. 1Charles University Prague, Medical Faculty Pilsen
  2. 2Charles University Prague, First Medical Faculty Prague; Czech Republic
  3. 3Institut fuer Klinische Chemie, University of Munich, Germany
  4. 4Medical Department II, LMU-Klinikum Grosshadern, University of Munich, Germany
  1. Correspondence to: Prof. Ondrej Topolcan, MD., Ph.D., Immunoanalytical Laboratory, Faculty Hospital Pilsen, E.Benese 13, 305 99 Pilsen, Czech Republic. e-mail: holubec{at}fnplzen.cz

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Changes of Thymidine Kinase (TK) During Adjuvant and Palliative Chemotherapy
O. TOPOLCAN, L. HOLUBEC, J. FINEK, P. STIEBER, S. HOLDENRIEDER, R. LAMERZ, L. HOLUBEC SEN, S. SVOBODOVA, V. VISOKAI, L. LIPSKA
Anticancer Research May 2005, 25 (3A) 1831-1833;
Twitter logo Facebook logo Mendeley logo

Jump to section